The Highwire

Liz James, Founder & President of Blessed by His Blood, and Tanya Lair—a physician assistant and mother of two daughters who require lifelong transfusions—share the fight to protect patients’ right to direct to donor blood after a decade-long donor arrangement was suddenly revoked. They unpack how a system meant to save lives can prioritize bureaucracy and profit over individualized care, and why this battle is spreading to legislatures across the country.

The rapidly accelerating AI revolution raises profound questions about jobs, human purpose, and economic survival as white-collar work is quietly displaced at scale. As universal basic income shifts from theory to political reality, a deeper question emerges: what happens to motivation, creativity, and freedom when human labor is no longer essential?

This week, under the leadership of Surgeon General Dr. Joseph Ladapo and Governor Ron DeSantis, Florida stepped in where federal regulators failed, uncovering heavy metals in baby formula and toxic “forever chemicals” in popular bottled waters through independent testing. As states begin to reveal what’s actually on store shelves, a deeper question emerges: why is consumer safety only now becoming a priority—and who was supposed to be protecting families all along?

Unresolved questions surrounding COVID-19 vaccine injuries have been brought into focus by contrasting public polling with official reporting systems, revealing how many serious adverse events may have gone uncounted. Jefferey exposes the glaring contradiction of vaccine architect Stanley Plotkin now calling for better detection, prevention, and compensation of vaccine injuries—after decades of defending a system that never properly studied or tracked them.

The legacy media response to changes in the childhood vaccine schedule questions why shared decision-making between patients and physicians is increasingly framed as dangerous. Far from a narrow health policy dispute, the controversy centers on bodily autonomy and parental choice—core measures of freedom in a country that professes trust in its citizens.

This week, Del opens on the media backlash to the CDC’s shift toward shared vaccine decision-making. Is the panic really about safety, or about empowering Americans with choice? Jefferey Jaxen delivers a wide-ranging investigation into COVID vaccine injury data, exposing massive underreporting through VAERS and V-safe, new polling that shows widespread harm, and even admissions from legacy vaccine leaders that current safety science is insufficient. Then, he reports on Florida’s discovery of mercury and other heavy metals in baby food, the presence of PFAS “forever chemicals” in popular bottled water brands, and the accelerating impact of artificial intelligence as it displaces white-collar jobs and pushes universal basic income into the political mainstream. Finally, a deeply personal and powerful conversation about medical freedom at its most fundamental level — blood — as Del recounts his own near-fatal medical emergency and the extraordinary effort required to secure a transfusion aligned with informed consent, while families share how the right to directed blood donations saved their children’s lives and how that right is now under threat.

Guests: Liz James, Tanya Lair, PA-C

Today on The HighWire, Del reveals why the CDC quietly changed its vaccines-autism page — now stating the claim “vaccines do not cause autism” is not evidence-based. Jefferey Jaxen covers the FDA’s bombshell disclosure that the COVID shot has killed at least 10 children, Europe’s rejection of Bovaer cow feed, and why flaws in a new Cochrane HPV study undermine claims it prevents cervical cancer. Then, Carrie Bigford (Texans for Vaccine Choice) shares tools she developed to help advocates confidently navigate vaccine discussions. We’ll check in live on the ACIP meeting, plus major news — ICAN will present to ACIP tomorrow at 9:30 AM ET. Del also sits down with Dr. Bob Sears to discuss MAHA leadership and the ACIP Hepatitis B vote.

Bitcoin (BTC) Donations: bc1qjglefjkj83n5y85kkwu72w6wh45mlm7ts05xxx

Monero (XMR) Donations: 87ZT6eQgoTPA2Qmzaquy5Ef6HkyLhmrBxBVosMyXerm2CBpMXKhVGo262ZFAmF3zQs9JHgS9TtGh1jjNnoUedeTK46vtMjG

In a historic move, the CDC revised the U.S. childhood vaccine schedule this week after a comprehensive review removed several vaccines from routine use—bringing the United States closer to alignment with other developed nations, including Denmark. The revision follows an assessment requested by President Donald Trump in December of 2025, in which HHS reviewed vaccination schedules across 20 peer developed countries. That review found the U.S. to be a global outlier, recommending vaccines for more diseases—and a higher total number of doses—than any comparable nation. Del breaks down what changed, what remains on the schedule, and how federal officials say the shift is intended to improve transparency and strengthen informed consent.

Sayer Ji, founder of GreenMedInfo and a named member of the so-called “Disinformation Dozen,” joins Del to discuss how the Center for Countering Digital Hate (CCDH), led by Imran Ahmed, targeted him and others—helping trigger widespread censorship across major tech platforms. Ji explains how NGOs, government pressure, and coordinated media narratives operate in tandem to suppress dissent, sidestep due process, and quietly redefine free speech under the banner of public health and safety. He also covers the controversial backlash against Imran Ahmed himself, a British-born legal permanent resident in the U.S. who is fighting efforts by the Trump administration to strip his visa and deport him.

Alarmist media coverage and public health messaging have branded this season’s flu a so-called “super flu,” but surveillance data from both the U.K. and the U.S. tell a more measured story. While reports of influenza-like illness (ILI) have risen—as they typically do during winter—rates of laboratory-confirmed influenza remain within normal seasonal levels. The distinction is often blurred in headlines, with ILI frequently conflated with confirmed flu infections. Even public health officials acknowledge these limitations, along with the well-documented constraints of flu vaccine effectiveness, raising questions about whether the current narrative reflects the data.